Proposes a function-based regulatory taxonomy for digital assets that prioritizes economic substance over technical form, with implications for genomic data tokens and consent-recording mechanisms.
Research & Publications
Actag's work is grounded in peer-reviewed research at the intersection of genomic data governance, blockchain technology, and privacy law.
Selected Publications by Seth C. Oranburg
The following publications inform Actag's regulatory and governance design.
Analyzes proposed federal legislation that would clarify the regulatory treatment of digital assets, with particular attention to data-backed tokens and decentralized governance structures.
Examines how blockchain architectures reconstitute personal data as property rather than as a regulated interest, and the implications for consent-based genomic data governance.
Applies antitrust doctrine to decentralized network structures, identifying where platform governance mechanisms may create anticompetitive effects relevant to genomic data marketplaces.
Literature Foundation
Actag's platform design is informed by a systematic review of 255 academic papers spanning 2009–2026, documenting the field's evolution from conceptual frameworks to operational deployments. The review covers blockchain-genomics architecture, privacy-preserving cryptography, regulatory compliance design, and consent management systems.
The literature establishes a clear trajectory: the field has matured from theoretical proposals to production-grade implementations, and the technical and legal infrastructure for responsible genomic data governance now exists. Key findings from the systematic review:
17×
Increase in annual publication rate (2023–2026 vs. prior baseline), indicating rapid field maturation.
60%
Of recent technical implementations use hybrid on-chain/off-chain architectures — the design approach Actag has adopted.
Viable
Privacy-preserving cryptography (zero-knowledge proofs, homomorphic encryption) is now operationally viable in genomic data contexts.
Questions About Our Research?
We welcome inquiries from researchers, clinicians, and policymakers.
Contact Us